Lisdexamfetamine dimesylate had no apparent effects on embryo-fetal morphological development or survival when administered orally to pregnant rats and rabbits throughout the period of organogenesis at doses of up to 40 and 120 mg/kg/day, respectively. Always seek the advice of your physician or other qualified health provider with any questions https://davidk409wnh6.wikicarrier.com/user